(Q42107264)

16 October 2017

0 references

FGFR1 as a novel prognostic and predictive biomarker in squamous cell cancers of the lung and the head and neck area (English)

1 reference

16 October 2017

0 references

Anne von Mässenhausen

1

1 reference

16 October 2017

Alina Franzen

2

1 reference

16 October 2017

Lynn Heasley

3

1 reference

16 October 2017

Sven Perner

4

1 reference

16 October 2017

1 October 2013

1 reference

Annals of Translational Medicine

16 October 2017

1 reference

16 October 2017

1

1 reference

16 October 2017

3

1 reference

16 October 2017

23

1 reference

Fibroblast growth factor receptor 1 amplification is a common event in squamous cell carcinoma of the head and neck

16 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200677

Fibroblast growth factor receptor 1 gene amplification is associated with poor survival and cigarette smoking dosage in patients with resected squamous cell lung cancer.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200677

Inhibitor-sensitive FGFR1 amplification in human non-small cell lung cancer

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200677

Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200677

ALK inhibition for non-small cell lung cancer: from discovery to therapy in record time

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200677

Cellular responses to EGFR inhibitors and their relevance to cancer therapy

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200677

Determining the profiles and parameters for gene amplification testing of growth factor receptors in lung cancer.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200677

Rationale for treatment of metastatic squamous cell carcinoma of the lung using fibroblast growth factor receptor inhibitors.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200677

Recurrent FGFR1 amplification and high FGFR1 protein expression in oral squamous cell carcinoma (OSCC).

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200677

10.3978/J.ISSN.2305-5839.2013.06.08

17 August 2018

Identifiers

DOI

1 reference

16 October 2017

1 reference

16 October 2017

PubMed publication ID

25332967

1 reference